Takeda Pharmaceutical Posts Higher Fiscal 2020 Core EPS, Revenue Declines
08:00 AM EDT, 05/11/2021 (MT Newswires) -- Takeda Pharmaceutical Co. (TAK) on Tuesday reported fiscal 2020 core earnings of 420 Japanese yen ($3.84) per share, up from 387 yen per share a year earlier.
Revenue was 3.2 billion yen for the fiscal year ended March 31, down from 3.29 billion yen a year ago.
For fiscal 2021, the company expects mid-single-digit growth in revenue and core EPS. The projected core EPS for the fiscal year is 394 yen, while revenue is expected to be 3.37 billion.
Price: 16.93, Change: -0.03, Percent Change: -0.18